Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1480-9222
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer ; volume:21 ; number:1 ; day:15 ; month:6 ; year:2019 ; pages:1-13 ; date:12.2019
Biological procedures online ; 21, Heft 1 (15.6.2019), 1-13, 12.2019
- Creator
-
Mazzucchelli, S.
Piccotti, F.
Allevi, R.
Truffi, M.
Sorrentino, L.
Russo, L.
Agozzino, M.
Signati, L.
Bonizzi, A.
Villani, L.
Corsi, F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12575-019-0099-8
- URN
-
urn:nbn:de:101:1-2019091009554243334427
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mazzucchelli, S.
- Piccotti, F.
- Allevi, R.
- Truffi, M.
- Sorrentino, L.
- Russo, L.
- Agozzino, M.
- Signati, L.
- Bonizzi, A.
- Villani, L.
- Corsi, F.
- SpringerLink (Online service)
Other Objects (12)
Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
Establishment of patient-derived organoids and a characterization based drug discovery platform for treatment of gastric cancer
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
In vitro drug testing using patient-derived ovarian cancer organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
Establishment of patient-derived organoids and a characterization based drug discovery platform for treatment of gastric cancer
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
In vitro drug testing using patient-derived ovarian cancer organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
Establishment of patient-derived organoids and a characterization based drug discovery platform for treatment of gastric cancer
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
In vitro drug testing using patient-derived ovarian cancer organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids